L2T1 Stock Overview
Engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
LifeVantage Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$23.80 |
| 52 Week High | US$24.20 |
| 52 Week Low | US$4.88 |
| Beta | 0.84 |
| 1 Month Change | 44.24% |
| 3 Month Change | 114.41% |
| 1 Year Change | 357.69% |
| 3 Year Change | 353.33% |
| 5 Year Change | 72.46% |
| Change since IPO | 88.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| L2T1 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 12.3% | 2.9% | 3.0% |
| 1Y | 357.7% | -3.6% | 12.8% |
Return vs Industry: L2T1 exceeded the German Personal Products industry which returned -3.6% over the past year.
Return vs Market: L2T1 exceeded the German Market which returned 12.8% over the past year.
Price Volatility
| L2T1 volatility | |
|---|---|
| L2T1 Average Weekly Movement | 16.4% |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: L2T1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: L2T1's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 222 | Steve Fife | www.lifevantage.com |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name.
LifeVantage Corporation Fundamentals Summary
| L2T1 fundamental statistics | |
|---|---|
| Market cap | €307.66m |
| Earnings (TTM) | €4.01m |
| Revenue (TTM) | €190.23m |
76.7x
P/E Ratio1.6x
P/S RatioIs L2T1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L2T1 income statement (TTM) | |
|---|---|
| Revenue | US$196.01m |
| Cost of Revenue | US$40.75m |
| Gross Profit | US$155.26m |
| Other Expenses | US$151.13m |
| Earnings | US$4.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 79.21% |
| Net Profit Margin | 2.11% |
| Debt/Equity Ratio | 0% |
How did L2T1 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield45%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 11:25 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LifeVantage Corporation is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alex Fuhrman | Craig-Hallum Capital Group LLC |
| Mitchell Pinheiro | Imperial Capital |
| Brooks O'Neil | Lake Street Capital Markets, LLC |